About advanced health genetics

Our Mission: Making Genetic Science Actionable

Advanced Health Genetics exists because we believe everyone deserves access to the insights hidden in their DNA—not locked behind academic jargon or expensive clinical tests, but translated into clear, actionable guidance you can actually use.

We combine peer-reviewed genetic imputation technology with expert medical oversight to analyze over 83 million genetic variants from a single DNA test. The result: personalized health reports that help you understand your body at its most fundamental level.

Why We Started: A Health Crisis That Changed Everything

Our founder, Elwin Robinson, spent years struggling with chronic fatigue, brain fog, and declining health. Doctors couldn't find answers. Specialists ran tests that came back 'normal.' Alternative practitioners offered guesswork dressed as certainty.

The breakthrough came when Elwin discovered his genetic data held clues that conventional medicine had missed. A methylation deficiency. Detoxification pathway variants. Nutrient absorption issues—all written in his DNA, waiting to be decoded.

"When I finally understood my genetic blueprint, everything changed," Elwin recalls. "I could see exactly which supplements my body needed, which foods to avoid, which lifestyle factors were working against me. Within months, the fog lifted. The energy returned."

That experience sparked a mission: make this level of genetic insight accessible to everyone—not just those with access to expensive clinical geneticists or the scientific background to interpret raw research papers

How Our Technology Works

We don't guess. We don't rely on outdated databases or oversimplified interpretations. Our analysis is built on three pillars of scientific rigor:

1. Genetic Imputation Technology: Consumer DNA tests like 23andMe and AncestryDNA measure approximately 750,000 genetic markers. Our imputation technology—powered by Omics Edge's bioinformatics platform—expands this to over 83 million variants by leveraging reference panels from the 1000 Genomes Project and Haplotype Reference Consortium.

2. Bayesian Deep Learning: Our AI doesn't hallucinate. Unlike generative AI systems (like ChatGPT) that can fabricate information, we use discriminative algorithms that only identify patterns in actual genetic data. The result is 99.7% accuracy for common variants—validated against whole genome sequencing datasets.

3. Ancestry-Adjusted Polygenic Risk Scores: Generic risk scores often fail for non-European populations because they were trained on limited datasets. Our algorithms adjust for your specific genetic ancestry, ensuring accurate insights regardless of your background.

Expert Oversight for Every Report

We don't just rely on algorithms. Our reports are developed under medical oversight and powered by one of the world's leading genetics technology teams.

Medical Advisor

Dr. Arif Ali, MBBS, RMP

Medical License: 781874-05-M

Dr. Arif Ali serves as AHG's Medical Advisor, providing clinical oversight of our report methodologies and ensuring our health recommendations align with medical best practices.

As a registered medical practitioner with experience bridging clinical medicine and personalized health technologies, Dr. Ali ensures that our genetic insights are presented in a clinically appropriate context. His oversight includes:

Review of report methodologies and clinical appropriateness
Ensuring recommendations include appropriate medical disclaimers
Guidance on when genetic insights should prompt consultation with healthcare providers
Clinical validation of supplement and lifestyle recommendations

Technology & Scientific Partner: Omics Edge

Our genetic analysis platform is powered by Omics Edge, a B2B bioinformatics company specializing in population genetics and personalized medicine. This partnership gives AHG access to world-class scientific infrastructure:

Scientific Team	70+ scientists, medical doctors, PhDs, and engineers
Technology Investment	Over $20 million in R&D and validation
Variant Coverage	83+ million genetic variants analyzed
Accuracy Rate	99.7% accuracy validated against whole genome sequencing
Expertise Areas	Population genetics, machine learning, cardiology, oncology, endocrinology, bioinformatics

The Omics Edge team continuously improves our algorithms, validates accuracy against independent datasets, and incorporates the latest peer-reviewed genetic research into our reports.

Learn more about our technology →

The 'Glass Box' Approach

In an industry often criticized for 'black box' algorithms and vague claims, we've chosen radical transparency:

Published Methodology: We document exactly how our imputation and analysis works, citing the academic research it's based on. [Link to /how-it-works]

Accuracy Metrics: We publish our validation results—99.7% accuracy for common variants, verified against whole genome sequencing benchmarks.

Confidence Scoring: Every insight in your report includes a confidence score, so you know which findings are highly certain and which are probabilistic.

Regular Updates: As new research emerges, we update our reports—and notify you when your insights have changed.

Clear Limitations: We're honest about what genetic testing can and can't tell you. We're not diagnostic. We don't replace your doctor. We provide insights that help you ask better questions.